Answers are grounded in this paper and cite their sources.
Obstacles to realizing the clinical benefits of continuous glucose monitoring (CGM) for daily diabetes management are being overcome with more affordable, user-friendly technologies. This article describes a novel category of CGM known as "flash" that may allow more routine use of continuous data for greater numbers of patients treated in primary care.
No takes yet. Share an insight, caveat, or question.
Hirsch et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: